XML 37 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Trade and other receivables
12 Months Ended
Dec. 31, 2022
Text block [abstract]  
Trade and other receivables
15.
Trade and other receivables
 
    
31.12.2021
RMB’000
    
31.12.2022
RMB’000
    
31.12.2022
US$’000
 
Trade receivables, gross
     364,445        1,549,462        222,883  
Less: Allowance for expected credit losses
     (33,210      (33,247      (4,782
    
 
 
    
 
 
    
 
 
 
Net trade receivables (Note 6.2)
     331,235        1,516,215        218,101  
Bills receivable
(i)
     6,437,100        4,970,880        715,039  
    
 
 
    
 
 
    
 
 
 
Total (Note 35, Note 36)
     6,768,335        6,487,095        933,140  
    
 
 
    
 
 
    
 
 
 
Amounts receivable:
                          
- associates and joint ventures (trade)
     243        125,489        18,051  
- associates and joint ventures
(non-trade)
     11,959        11,230        1,615  
- related parties (trade)
     68,539        180,374        25,946  
- related parties
(non-trade)
     459        3,476        500  
Bills receivable in transit
     22,360        8,172        1,176  
Grant receivables
            62,000        8,919  
Interest receivables
     11,788        15,437        2,221  
Others
     29,663        34,326        4,937  
Less: Impairment losses – other receivables
     (6,231      (5,754      (828
    
 
 
    
 
 
    
 
 
 
Other receivables carried at amortized cost (Note 35)
     138,780        434,750        62,537  
Tax recoverable
     328,369        290,596        41,801  
Advances paid to suppliers
     66,474        81,861        11,775  
Right of return assets
     40,761        17,045        2,452  
    
 
 
    
 
 
    
 
 
 
Net other receivables
     574,384        824,252        118,565  
    
 
 
    
 
 
    
 
 
 
Total trade and other receivables
     7,342,719        7,311,347        1,051,705  
    
 
 
    
 
 
    
 
 
 
Note:

 
(i)
 
As of December 31, 2022, bills receivable includes bills received from joint ventures and related parties amounted to RMB 0.1 million (US$ less than 0.1 million) (2021: RMB 0.7 million) and RMB 763.4 million (US$ 109.8 million) (2021: RMB 523.5 million) respectively.
As of December 31, 2022, bills receivable amounted to RMB 12.6 million (US$ 1.8 million) (2021: RMB 13.4 million) was pledged to secure bank facilities.
Trade receivables are non-interest bearing and are generally on 60 - 90 days’ term. They are recognized at their original invoice amounts, net of sales rebates in the financial year.
Non-trade
balance from associates, joint ventures and other related parties are unsecured, interest-free, and repayable on demand.
 
 
 
Movement in the allowance for expected credit losses of trade and other receivables is as follows:
 
    
31.12.2021
RMB’000
    
31.12.2022
RMB’000
    
31.12.2022
US$’000
 
At January 1
     50,260        39,441        5,674  
Credit to consolidated statement of profit or loss (under “Selling, general and administrative expenses”)
     (8,525      (459      (66
Written off
     (2,278      (5      (1
Translation difference
     (16      24        3  
    
 
 
    
 
 
    
 
 
 
At December 31
     39,441        39,001        5,610  
    
 
 
    
 
 
    
 
 
 
As of December 31, 2021 and 2022, outstanding bills receivable discounted with banks for which the Group retained a recourse obligation totaled RMB 79.1 million and RMB 936.9 million (US$ 134.8 million) respectively. All bills receivable discounted have contractual maturities within 12 months at time of discounting.
As of December 31, 2021 and 2022, outstanding bills receivable endorsed to suppliers with recourse obligation were RMB 2,550.0 million and RMB 1,032.1 million (US$ 148.5 million) respectively.
As of December 31, 2021 and 2022, trade receivables due from a major customer, Dongfeng Automobile Co., Ltd. and its affiliates (the “Dongfeng companies”) were RMB
29.2 million and RMB 662.7 million (US$ 95.3 million), respectively. See Note 32 for further discussion of customer concentration risk.
For terms and conditions relating to related parties, refer to Note 29.